sidebanner2009

5th Annual Platelet Colloquium Print

5th Annual Platelet Colloquium
January 28-30, 2010
Willard InterContinental Hotel
Washington, DC

Attendance is by invitation only.

The meeting will be cochaired by Richard C. Becker, MD of Duke University Medical Center; Susan S. Smyth, MD, PhD of the University of Kentucky; and Harold L. Dauerman, MD of the University of Vermont.

Overview
The overarching theme for the Colloquium's 5th year anniversary program is the translation of fundamental scientific constructs in platelet biology to safe and effective patient care on a global scale.  To this end, platelet genetics, genomics, proteomics and pharmacogenetics will serve as the underpinnings for scholarly discussions around inherited and acquired variations in function and their collective impact on response to pharmacologic treatments.  A bench-to-bedside forum will feature basic science on platelet receptors and platforms for successful drug development.
Objectives

1. Discuss the evolution of understanding in platelet genetics, genomics, and proteomics as a vital platform for translational research initiatives.


2. Discuss the potential clinical relevance of genetic polymorphisms, sex, ethnicity, and race on present and future drug development, patient-specific applications, risks, and benefits of platelet-directed pharmacotherapies.

3. Highlight advances in platelet biology that have transformed ideas into standards of care— tracing the formative roots from bench to bedside.

Agenda
icon Agenda 2010 (31.48 kB)

Grants
Educational grants were provided by the following companies:

  • AstraZeneca
  • Bristol-Myers Squibb/Sanofi Partnership
  • Daiichi Sankyo, Inc. and Lilly USA, LLC (manuscript grant only)
  • Regado Biosciences, Inc.
  • Merck Research Laboratories
  • The Medicines Company

View Previous Meetings